Active ingredientBenznidazoleCat. No. P-B042-001CAS 22994-85-0Family · Pharmaceutical analytical standards
Benznidazole
A nitroimidazole antiparasitic, in use since 1971 as the first-line treatment for Chagas disease, the infection caused by the protozoan Trypanosoma cruzi. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?Despite decades of use, only in 2017 did it become the first medicine approved in the United States for Chagas disease, initially for children aged 2 to 12.
Go to the active ingredient →Active ingredientBenznidazoleCat. No. P-B042-001CAS 22994-85-0
Isotopically labelledBenznidazole-D7Cat. No. P-B042-002
NitrosamineN-Nitroso BenznidazoleCat. No. P-B042-003
Impurity2,3,4-Trihydroxybenzyl AlcoholCat. No. P-B042-004CAS 437988-46-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.